Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04043676
Title Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion Teofilo Hernando, Spain
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.